-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UFSZ+dK+CBKohSfrj/SIGoARtnnh9lS7HEe3vgfZmcl+xYxi5muYidYN5Vgo4PQ3 v9UfZaGbPg0I6uoArVUDtw== 0000950162-03-001047.txt : 20030725 0000950162-03-001047.hdr.sgml : 20030725 20030725160632 ACCESSION NUMBER: 0000950162-03-001047 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030725 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ELAN CORP PLC CENTRAL INDEX KEY: 0000737572 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: LINCOLN HOUSE LINCOLN PLACE STREET 2: COUNTY WESTMEATH CITY: DUBLIN 2 IRELAND STATE: L2 BUSINESS PHONE: 3537094000 MAIL ADDRESS: STREET 1: LINCOLN HOUSE LINCOLN PLACE STREET 2: EIGHTY PINE STREET CITY: DUBLIN 2 IRELAND STATE: L2 ZIP: 00000 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DOV PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001066833 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223374365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-78237 FILM NUMBER: 03803785 BUSINESS ADDRESS: STREET 1: 433 HACKENSACK AVENUE CITY: HACKENSACK STATE: NJ ZIP: 07601 BUSINESS PHONE: 2019680980 MAIL ADDRESS: STREET 1: 433 HACKENSACK AVENUE CITY: HACKENSACK STATE: NJ ZIP: 07601 SC 13G 1 elancorp13g072503.txt SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 DOV Pharmaceutical, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $.0001 per Share - -------------------------------------------------------------------------------- (Title of Class of Securities) 259858108 - -------------------------------------------------------------------------------- (CUSIP Number) April 24, 2002 (IPO Date) and December 31, 2002 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) / / Rule 13d-1(c) /X/ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP 259858108 SCHEDULE 13G -2- - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Elan Corporation, plc - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / (b) / / - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Ireland - -------------------------------------------------------------------------------- 5. Sole Voting Power 0 ----------------------------------------------------- Number of 6. Shared Voting Power Shares Beneficially 4,044,264 ----------------------------------------------------- Owned by Each 7. Sole Dispositive Power Reporting Person With: 0 ----------------------------------------------------- 8. Shared Dispositive Power 4,044,264 - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,044,264 - -------------------------------------------------------------------------------- 10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 20.4% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) CO CUSIP 259858108 SCHEDULE 13G -3- - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Elan International Services, Ltd. - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / (b) / / - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Bermuda - -------------------------------------------------------------------------------- 5. Sole Voting Power 0 ----------------------------------------------------- Number of 6. Shared Voting Power Shares Beneficially 4,044,264 ----------------------------------------------------- Owned by Each 7. Sole Dispositive Power Reporting Person With: 0 ----------------------------------------------------- 8. Shared Dispositive Power 4,044,264 - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,044,264 - -------------------------------------------------------------------------------- 10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 20.4% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) CO CUSIP 259858108 SCHEDULE 13G -4- - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Elan Pharmaceutical Investments Ltd. - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) / / (b) / / - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Bermuda - -------------------------------------------------------------------------------- 5. Sole Voting Power 0 ----------------------------------------------------- Number of 6. Shared Voting Power Shares Beneficially 1,221,046 ----------------------------------------------------- Owned by Each 7. Sole Dispositive Power Reporting Person With: 0 ----------------------------------------------------- 8. Shared Dispositive Power 1,221,046 - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,221,046 - -------------------------------------------------------------------------------- 10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row (9) 7.2% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) CO CUSIP 259858108 SCHEDULE 13G -5- Item 1(a). Name of Issuer: DOV Pharmaceutical, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 433 Hackensack Avenue, Hackensack, New Jersey 07601 Item 2(a). Name of Person Filing: This statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons") (i) Elan Corporation, plc (ii) Elan International Services, Ltd. (iii) Elan Pharmaceutical Investments Ltd. Item 2(b). Address of Principal Business Office: (i) Elan Corporation, plc Lincoln House, Lincoln Place Dublin 2, Ireland (ii) Elan International Services, Ltd. 102 St. James Court Flatts, Smiths FL 04 Bermuda (iii) Elan Pharmaceutical Investments Ltd. 102 St. James Court Flatts, Smiths FL 04 Bermuda Item 2(c). Citizenship: (i) Elan Corporation, plc is an Irish public limited company (ii) Elan International Services, Ltd. is a Bermuda exempted limited liability company (iii) Elan Pharmaceutical Investments Ltd. is a Bermuda exempted limited liability company Item 2(d). Title of Class of Securities: Common Stock, par value $.0001 per share (the "Shares") Item 2(e). CUSIP Number: 259858108 Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b) or 240.13d-2(b) or (c), check whether the person is a: This Item 3 is not applicable CUSIP 259858108 SCHEDULE 13G -6- Item 4. Ownership: Elan Corporation plc (a) Amount beneficially owned: 4,044,264 (1) (b) Percent of class: 20.4% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 (ii) shared power to vote or to direct the vote: 4,044,264 (1) (iii) sole power to dispose or to direct the disposition of: 0 (iv) shared power to dispose or to direct the disposition of: 4,044,264 (1) Elan International Services, Ltd. (a) Amount beneficially owned: 4,044,264 (b) Percent of class: 20.4% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 (ii) shared power to vote or to direct the vote: 4,044,264 (iii) sole power to dispose or to direct the disposition of: 0 (iv) shared power to dispose or to direct the disposition of: 4,044,264 Elan Pharmaceutical Investments Ltd. (a) Amount beneficially owned: 1,221,046 (b) Percent of class: 7.2% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 (ii) shared power to vote or to direct the vote: 1,221,046 (iii) sole power to dispose or to direct the disposition of: 0 (iv) shared power to dispose or to direct the disposition of: 1,221,046 CUSIP 259858108 SCHEDULE 13G -7- - ---------- (1) 2,823,218 of the shares are beneficially owned directly by Elan International Services, Ltd., a direct wholly-owned subsidiary of Elan Corporation, plc, and 1,221,046 of the shares are beneficially owned directly by Elan Pharmaceutical Investments Ltd., a direct wholly-owned subsidiary of Elan International Services, Ltd. CUSIP 259858108 SCHEDULE 13G -8- Item 5. Ownership of Five Percent or Less of a Class: Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person: Not Applicable Item 8. Identification and Classification of Members of the Group: Not Applicable Item 9. Notice of Dissolution of Group: Not Applicable Item 10. Certifications: Not Applicable. CUSIP 259858108 SCHEDULE 13G -9- SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: July 25, 2003 ELAN CORPORATION, PLC By: /s/ Liam Daniel ---------------------------- Name: Liam Daniel Title: Secretary Dated: July 25, 2003 ELAN INTERNATIONAL SERVICES, LTD. By: /s/ Kevin Insley ---------------------------- Name: Kevin Insley Title: President Dated: July 25, 2003 ELAN PHARMACEUTICAL INVESTMENTS LTD. By: /s/ Kevin Insley ---------------------------- Name: Kevin Insley Title: President CUSIP 259858108 SCHEDULE 13G -10- EXHIBIT INDEX Page No. A. Joint Filing Agreement dated July 25, 2003 by and among Elan Corporation, plc, Elan International Services, Ltd. and Elan Pharmaceutical Investments Ltd...............................................................13 CUSIP 259858108 SCHEDULE 13G -11- EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of DOV Pharmaceutical, Inc., dated as of July 25, 2003 is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. Dated: July 25, 2003 ELAN CORPORATION, PLC By: /s/ Liam Daniel ---------------------------- Name: Liam Daniel Title: Secretary Dated: July 25, 2003 ELAN INTERNATIONAL SERVICES, LTD. By: /s/ Kevin Insley ---------------------------- Name: Kevin Insley Title: President Dated: July 25, 2003 ELAN PHARMACEUTICAL INVESTMENTS LTD. By: /s/ Kevin Insley ---------------------------- Name: Kevin Insley Title: President -----END PRIVACY-ENHANCED MESSAGE-----